These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25697038)

  • 1. [New trial designs and potential therapies for pulmonary artery hypertension].
    Gomberg-Maitland M; Bull TM; Saggar R; Barst RJ; Elgazayerly A; Fleming TR; Grimminger F; Rainisio M; Stewart DJ; Stockbridge N; Ventura C; Ghofrani AH; Rubin LJ
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 1():106-18. PubMed ID: 25697038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New trial designs and potential therapies for pulmonary artery hypertension.
    Gomberg-Maitland M; Bull TM; Saggar R; Barst RJ; Elgazayerly A; Fleming TR; Grimminger F; Rainisio M; Stewart DJ; Stockbridge N; Ventura C; Ghofrani AH; Rubin LJ
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D82-91. PubMed ID: 24355645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic thromboembolic pulmonary hypertension].
    Kim NH; Delcroix M; Jenkins DP; Channick R; Dartevelle P; Jansa P; Lang I; Madani MM; Ogino H; Pengo V; Mayer E
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 1():119-29. PubMed ID: 25697039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial designs in PAH: shifting from functional measurements to long-term clinical outcomes.
    Studer SM; Gilkin RJ
    Am J Manag Care; 2014 Mar; 20(6 Suppl):S115-22. PubMed ID: 24716456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
    Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
    Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary arterial hypertension: epidemiology and registries].
    McGoon MD; Benza RL; Escribano-Subias P; Jiang X; Miller DP; Peacock AJ; Pepke-Zaba J; Pulido T; Rich S; Rosenkranz S; Suissa S; Humbert M
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 1():67-77. PubMed ID: 25697035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy in the management of pulmonary arterial hypertension.
    Buckley MS; Staib RL; Wicks LM
    Int J Clin Pract Suppl; 2013 May; (179):13-23. PubMed ID: 23578069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Updated treatment algorithm of pulmonary arterial hypertension].
    Galiè N; Corris PA; Frost A; Girgis RE; Granton J; Jing ZC; Klepetko W; McGoon MD; McLaughlin VV; Preston IR; Rubin LJ; Sandoval J; Seeger W; Keogh A
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 1():78-94. PubMed ID: 25697036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for pulmonary hypertension: prospects and challenges.
    Reynolds PN
    Expert Opin Biol Ther; 2011 Feb; 11(2):133-43. PubMed ID: 21219232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial hypertension: pharmacologic therapies and potential pulmonary artery denervation treatment.
    Zhang YJ; Li MH; Chen SL
    EuroIntervention; 2013 May; 9 Suppl R():R149-54. PubMed ID: 23732148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of pulmonary arterial hypertension.
    Adamali H; Gaine SP; Rubin LJ
    Semin Respir Crit Care Med; 2009 Aug; 30(4):484-92. PubMed ID: 19634087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary hypertension due to left heart diseases].
    Vachiéry JL; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs JS; Martinez F; Semigran M; Simonneau G; Wells A; Seeger W
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 1():130-41. PubMed ID: 25697040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future therapeutic targets for pulmonary arterial hypertension.
    Fraidenburg D; Yuan J
    High Alt Med Biol; 2013 Jun; 14(2):134-43. PubMed ID: 23795733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging treatments for pulmonary arterial hypertension.
    O'Callaghan DS
    Clin Respir J; 2008 Jul; 2(3):132-40. PubMed ID: 20298321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging therapies and future directions in pulmonary arterial hypertension.
    Gurtu V; Michelakis ED
    Can J Cardiol; 2015 Apr; 31(4):489-501. PubMed ID: 25840098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.
    Waxman AB; Zamanian RT
    Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future.
    Malenfant S; Margaillan G; Loehr JE; Bonnet S; Provencher S
    Expert Rev Respir Med; 2013 Feb; 7(1):43-55. PubMed ID: 23362814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging drugs for pulmonary hypertension.
    Girgis RE
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):71-85. PubMed ID: 20095920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.